Is Winifred Masterson Burke Medical Research Legit?

Winifred Masterson Burke Medical Research has consistently operated with expenses exceeding revenue over the past decade, indicating a reliance on prior reserves or other funding mechanisms not immediately apparent in annual revenue figures. For instance, in 2023, expenses were $17,890,786 against revenues of $15,401,317, a deficit of over $2.4 million. This trend is consistent across all reported periods, suggesting a structural deficit in its operational model. The organization's assets have also shown a significant decline, from $14,523,564 in 2018 to $7,823,857 in 2023, while liabilities have generally increased, reaching $12,678,191 in 2023, exceeding its assets. This financial trajectory raises concerns about long-term sustainability. Regarding spending efficiency, without a detailed breakdown of program, administrative, and fundraising expenses, it's challenging to fully assess. However, the consistent operational deficits suggest that the organization is spending more than it brings in annually. The reported 0% officer compensation across all filings is unusual and could indicate that executive salaries are reported under other expense categories or that the organization relies heavily on volunteer leadership, which would be a positive indicator for efficiency if true. Further investigation into the detailed expense categories would be necessary to fully understand spending efficiency. Transparency appears to be adequate in terms of filing its IRS 990s, as evidenced by the extensive filing history. However, the lack of reported officer compensation in the summary data provided is a point that warrants further scrutiny for complete transparency. The consistent deficits and declining asset base are significant financial indicators that would benefit from clear explanations within the organization's public reporting.